|1.||Rossetto, André Luiz: 2 articles (01/2014 - 11/2012)|
|2.||Cruz, Rosana Cé Bella: 2 articles (01/2014 - 11/2012)|
|3.||Thaker, Saket J: 2 articles (11/2013 - 11/2013)|
|4.||Dave, Jayendra N: 2 articles (11/2013 - 11/2013)|
|5.||Shah, Hiral A: 2 articles (11/2013 - 11/2013)|
|6.||Mehta, Dimple S: 2 articles (11/2013 - 11/2013)|
|7.||Singal, Archana: 2 articles (07/2008 - 01/2005)|
|8.||Seabury Stone, Mary: 1 article (11/2014)|
|9.||Ely, John W: 1 article (11/2014)|
|10.||Rosenfeld, Sandra: 1 article (11/2014)|
|1.||Tinea Pedis (Athlete's Foot)
02/01/1997 - "Butenafine applied twice daily for 1 week is highly effective in treating interdigital tinea pedis."
02/01/1997 - "We evaluated the safety and efficacy of twice-daily butenafine versus its vehicle in the treatment of interdigital tinea pedis in a multicenter, randomized, double-blind, parallel-group trial. "
02/01/1997 - "One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial."
02/01/1997 - "We evaluated butenafine in the treatment of tinea pedis in a controlled, randomized, double-blind trial. "
03/01/2000 - "If incorporated properly in semisolid topical preparations, with a balanced vehicle, butenafine hydrochloride potentially exhibits as a promising alternative antimycotic agent for the treatment of tinea pedis."
02/01/1997 - "Butenafine applied once daily for 2 weeks is effective in treating tinea cruris. "
02/01/1997 - "We compared the safety and efficacy of butenafine hydrochloride and its vehicle when used once daily for 2 weeks to treat tinea cruris. "
03/01/2003 - "Randomised controlled trial of topical butenafine in tinea cruris and tinea corporis."
08/01/1997 - "A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent."
02/01/1997 - "Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial."
07/01/2008 - "To review pharmacokinetics, mechanism of actions and clinical efficacy of butenafine against various dermatophytic and other superficial fungal infections. "
02/01/1997 - "Update on topical therapy for superficial fungal infections: focus on butenafine."
11/01/1990 - "Butenafine (0.1 ml) in 0.2 to 1.0% solutions was applied to the site of infection. "
11/01/1990 - "The efficacy of butenafine was investigated in an experimental tinea pedis model in guinea pigs, which is pathologically similar to natural infections in humans. "
03/01/1998 - "Butenafine is a new antifungal agent with primary fungicidal activity against dermatophytes such as Trichophyton mentagrophytes, Microsporum canis and Trichophyton rubrum which cause tinea infections. "
02/01/1993 - "The excellent therapeutic efficacy of butenafine on experimental dermatophytosis may be attributed to its low MIC and good penetration and distribution in the horny layer and hair follicles, where fungi reside."
11/01/1990 - "Topical butenafine showed excellent efficacy against dermatophytosis when it was applied once daily, and the effect was superior to those of all four reference drugs. "
11/01/1990 - "The good efficacy of butenafine against dermatophytosis may be attributable to its fungicidal activity and long retention in the skin after topical application."
01/01/2014 - "The patient received guidance on accidents and animal bites and evolved well treated with topical butenafine for the dermatomycosis. "
11/01/1990 - "Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs."
|5.||Onychomycosis (Tinea Unguium)
10/01/1998 - "In conclusion, the mycologic and overall assessment of this study demonstrate that 2% butenafine HCl and 20% urea incorporated in a cream for keratinolysis is safe to use and significantly more effective than placebo in curing big toenail onychomycosis."
04/01/1999 - "The objective of this randomized, double-blind, placebo-controlled study was to examine the clinical efficacy and tolerability of 2% butenafine hydrochloride and 5% Melaleuca alternifolia oil incorporated in a cream to manage toenail onychomycosis in a cohort. "
04/01/1999 - "Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream."
10/01/1998 - "The purpose of this placebo-controlled, double-blind study was to determine the clinical efficacy, chemical avulsion, and tolerability of 2% butenafine hydrochloride and 20% urea incorporated in a cream to cure toenail onychomycosis in a preselected population. "
10/01/1998 - "Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study."